Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 21 Sep 2021

Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study

in Respiratory Pharmacology

Wei Cheng
Jiaxi Duan
Aiyuan Zhou
Yiyang Zhao
Rong Yi
Yi Liu
Dingding Deng
Xin Li
Yuqin Zeng
Yating Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2021.753653

4,305 views
18 citations

Original Research

Published on 16 Sep 2021

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

in Respiratory Pharmacology

Weimou Chen
Jinming Zhang
Wenshan Zhong
Yuanyuan Liu
Ye Lu
Zhaojin Zeng
Haohua Huang
Xuan Wan
Xiaojing Meng
Fei Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.744826

8,261 views
37 citations

Review

Published on 15 Sep 2021

Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

in Respiratory Pharmacology

Xu-Qin Du
Li-Peng Shi
Wen-Fu Cao
Zhi-Wei Chen
Biao Zuo
Jin-Yuan Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.708636

9,763 views
18 citations

Review

Published on 14 Sep 2021

Necroptosis in Pulmonary Diseases: A New Therapeutic Target

in Respiratory Pharmacology

Lingling Wang
Ling Zhou
Yuhao Zhou
Lu Liu
Weiling Jiang
Huojun Zhang
Huiguo Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.737129

9,063 views
19 citations

General Commentary

Published on 09 Sep 2021

Commentary: Description of Clinical Characteristics of VAP Patients in MIMIC Database

in Respiratory Pharmacology

Yun Li
Xuan Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.736447

2,276 views

Original Research

Published on 08 Sep 2021

LncRNA Nqo1-AS1 Attenuates Cigarette Smoke-Induced Oxidative Stress by Upregulating its Natural Antisense Transcript Nqo1

in Respiratory Pharmacology

Haiyun Zhang
Ruijuan Guan
Zili Zhang
Defu Li
Jingyi Xu
Yuxin Gong
Xin Chen
Wenju Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.729062

2,876 views
12 citations

Clinical Trial

Published on 02 Sep 2021

Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial

in Respiratory Pharmacology

Chang Chen
Yi Zhang
Jianying Huang
Ping Yin
Zhenshun Cheng
Jianyuan Wu
Song Chen
Yongxi Zhang
Bo Chen
Mengxin Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.683296

22,494 views
126 citations

Original Research

Published on 27 Aug 2021

Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics

in Respiratory Pharmacology

Abdul Basit
Asad Mustafa Karim
Muhammad Asif
Tanveer Ali
Jung Hun Lee
Jeong Ho Jeon
Shafiq ur Rehman
Sang Hee Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2021.731828

5,907 views
17 citations

Original Research

Published on 26 Aug 2021

Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice

in Respiratory Pharmacology

Xiaohe Li
Rui Liu
Yunyao Cui
Jingjing Liang
Zhun Bi
Shimeng Li
Yang Miao
Liang Zhang
Xiaoping Li
Honggang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2021.692346

5,704 views
8 citations

Original Research

Published on 23 Aug 2021

Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis

in Respiratory Pharmacology

Jinming Zhang
Wenshan Zhong
Yuanyuan Liu
Weimou Chen
Ye Lu
Zhaojin Zeng
Yujie Qiao
Haohua Huang
Xuan Wan
Wei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.708462

5,902 views
14 citations

Original Research

Published on 23 Aug 2021

Adiponectin Inhibits the Production of TNF-α, IL-6 and Chemokines by Human Lung Macrophages

in Respiratory Pharmacology

Hélène Salvator
Stanislas Grassin-Delyle
Marion Brollo
Louis-Jean Couderc
Charlotte Abrial
Tatiana Victoni
Emmanuel Naline
Philippe Devillier

Frontiers in Pharmacology

doi 10.3389/fphar.2021.718929

5,114 views
31 citations

Methods

Published on 19 Aug 2021

A Novel Processing-Free Method for RNAseq Analysis of Spontaneous Sputum in Chronic Obstructive Pulmonary Disease

in Respiratory Pharmacology

Francesca Ricci
Michele Bassi
Cathy M. McGeough
Gera L. Jellema
Mirco Govoni

Frontiers in Pharmacology

doi 10.3389/fphar.2021.704969

3,962 views
4 citations

Review

Published on 17 Aug 2021

Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects

in Respiratory Pharmacology

Xianbo Wu
Jianli Huang
Jie Wang
Yihua Xu
Xinwei Yang
Minghan Sun
Jianyou Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.707491

5,882 views
12 citations

Original Research

Published on 12 Aug 2021

Laryngopharyngeal pH Monitoring in Patients With Idiopathic Pulmonary Fibrosis

in Respiratory Pharmacology

Yiliang Su
Li Shen
Fen Zhang
Xing Jiang
Xiaofeng Jin
Yuan Zhang
Yang Hu
Ying Zhou
Qiuhong Li
Huiping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.724286

3,100 views
2 citations

Case Report

Published on 12 Aug 2021

Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen—Case Series Report

in Respiratory Pharmacology

Damir Vukoja
Andrea Jurić
Zdravka Erkapić
Tomislav Pejić
Željko Zovko
Josipa Juričić
Jelena Pejić
Matea Ćorluka

Frontiers in Pharmacology

doi 10.3389/fphar.2021.684537

6,782 views
1 citation

Case Report

Published on 09 Aug 2021

Case Report: Can Inhaled Adenosine Attenuate COVID-19?

in Respiratory Pharmacology

Bruce D. Spiess
Michael Sitkovsky
Pierpaolo Correale
Nikolaus Gravenstein
Cynthia Garvan
Timothy E. Morey
Brenda G. Fahy
Leslie Hendeles
Thomas J. Pliura
Thomas D. Martin

Frontiers in Pharmacology

doi 10.3389/fphar.2021.676577

3,595 views
10 citations